Olszewski Recaps Results of Mosunetuzumab in Elderly/Unfit DLBCL

Adam J. Olszewski, MD, discusses the promising results of a phase 1b/2 study of mosunetuzumab for elderly/unfit patients with previously untreated diffuse large B-cell lymphoma.

Related Keywords

Brown University ,Rhode Island ,United States ,Rhode Island Hospital ,Adamj Olszewski , ,News ,Videos ,Dlbcl ,D ,Elderly Unfit Patients With Previously Untreated Diffuse Largeb Cell Lymphoma ,Diffuse Largeb Cell Lymphoma ,Lymphoma ,Nct03677154 ,Phase 1b 2 Study Nct03677154 ,Mosunetuzumab ,Lunsumio ,